CD4 and neoplasm: Interestingly, simultaneous PD-L1 blockade and CD4+ T cell depletion additively suppressed tumor growth, resulting in tumor regression, while CD8+ T cell depletion completely reversed the antitumor effects of anti-PD-L1 therapy (Figure 1(a) and Supplementary Figure S3).